Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WILLIAM CONTE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1467794271
CMS profile
917618
Location
MERRILLVILLE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$176,822.26

369 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 6 of 8; records 251–300 of 369 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WILLIAM CONTE

NPI 1467794271 · CMS profile ID 917618

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

MERRILLVILLE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 8; records 251–300 of 369 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467794271?year=2023&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WILLIAM CONTE, NPI 1467794271, CMS profile ID 917618. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 8; records 251–300 of 369 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467794271?year=2023&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). WILLIAM CONTE, NPI 1467794271, CMS profile ID 917618. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 8; records 251–300 of 369 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467794271?year=2023&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
WILLIAM CONTE, NPI 1467794271, CMS profile ID 917618, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 8; records 251–300 of 369 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1467794271?year=2023&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

369 matching records · $176,822.26 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 369 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 369.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
EMD Serono, Inc. $17.6705/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032346249 CMS
Otsuka America Pharmaceutical, Inc. $18.8305/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014286751 CMS
UPSHER-SMITH LABORATORIES LLC $14.1005/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994133569 CMS
AbbVie Inc. $15.6704/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996506311 CMS
TG Therapeutics, Inc. $407.8004/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051503305 CMS
TG Therapeutics, Inc. $3,200.0004/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051503331 CMS
TG Therapeutics, Inc. $158.7404/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051503535 CMS
Biogen, Inc. $19.8304/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012153419 CMS
EMD Serono, Inc. $26.4604/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032524995 CMS
Novartis Pharmaceuticals Corporation $16.6004/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991436545 CMS
TG THERAPEUTICS, INC. $117.5904/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051503247 CMS
TG THERAPEUTICS, INC. $352.6304/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051503249 CMS
GENZYME CORPORATION $21.8104/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050316051 CMS
GENZYME CORPORATION $1,962.0004/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050316071 CMS
Genentech USA, Inc. $66.2804/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040597303 CMS
PFIZER INC. $18.2904/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049160389 CMS
GENZYME CORPORATION $69.3104/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050316055 CMS
TG Therapeutics, Inc. $28.8604/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051503251 CMS
EMD Serono, Inc. $12.6604/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032527729 CMS
GENZYME CORPORATION $112.2404/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050316031 CMS
Novartis Pharmaceuticals Corporation $24.2504/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991436549 CMS
Neurocrine Biosciences, Inc. $27.4704/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051999363 CMS
EMD Serono, Inc. $40.8004/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032492371 CMS
Novartis Pharmaceuticals Corporation $14.9404/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991436597 CMS
Biogen, Inc. $145.9404/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012248161 CMS
Lilly USA, LLC $29.0404/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032508161 CMS
EMD Serono, Inc. $3.4504/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032506929 CMS
Horizon Therapeutics plc $12.6204/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986975887 CMS
BANNER LIFE SCIENCES, LLC $22.7104/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021110181 CMS
Genentech USA, Inc. $21.6204/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040597285 CMS
Radius Health, Inc. $13.5904/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1024720265 CMS
Celgene Corporation $7.3704/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015162151 CMS
Celgene Corporation $20.3504/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015162161 CMS
EMD Serono, Inc. $26.2004/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032506889 CMS
Novartis Pharmaceuticals Corporation $2.8904/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991436593 CMS
Eisai Inc. $23.1104/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023337263 CMS
TG Therapeutics, Inc. $24.7504/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051503269 CMS
Corium, LLC $23.2304/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978000413 CMS
BANNER LIFE SCIENCES, LLC $17.4504/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021109783 CMS
Axsome Therapeutics, Inc. $19.7704/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056225985 CMS
Biogen, Inc. $125.0004/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012137909 CMS
PFIZER INC. $11.7303/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049506019 CMS
BANNER LIFE SCIENCES, LLC $237.5003/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021109563 CMS
BANNER LIFE SCIENCES, LLC $3,250.0003/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021109565 CMS
Novartis Pharmaceuticals Corporation $9.4903/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991436589 CMS
AbbVie Inc. $14.0903/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996506307 CMS
AbbVie Inc. $26.3303/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996506303 CMS
Alexion Pharmaceuticals, Inc. $1,770.0003/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017004097 CMS
ACADIA Pharmaceuticals Inc $12.9603/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053124765 CMS
EMD Serono, Inc. $13.3403/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032450217 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $93,100.59 317
PY2020 $54,207.99 275
PY2021 $138,946.02 361
PY2022 $240,215.39 491
PY2023 $176,822.26 369
PY2024 $245,305.37 422
PY2025 $276,180.18 403

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $72,561.09 7
PY2024 Recipient $1,377.23 10
PY2024 Principal investigator $130,716.78 5
PY2023 Recipient $8,289.33 1
PY2023 Principal investigator $241,151.02 2
PY2022 Principal investigator $65,039.80 3
PY2021 Principal investigator $1,214.35 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GENZYME CORPORATION $14,495.09 11/17/2025 Covered Recipient Teaching Hospital
Methodist Hospitals Inc
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226120254
Principal investigator 1 Novartis Pharmaceuticals Corporation $102.60 10/28/2025 Non-covered Recipient Entity
METHODIST HOSPITALS NEUROSCIENCE INSTITUTE
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190302329
Principal investigator 1 GENZYME CORPORATION $18,804.06 07/28/2025 Covered Recipient Teaching Hospital
Methodist Hospitals Inc
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis No dispute reported 06/30/2026 1226120251
Principal investigator 1 Novartis Pharmaceuticals Corporation $15,298.58 02/20/2025 Covered Recipient Teaching Hospital
Methodist Hospitals Inc
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190295273
Principal investigator 1 GENZYME CORPORATION $2,336.40 01/13/2025 Covered Recipient Teaching Hospital
Methodist Hospitals Inc
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis No dispute reported 06/30/2026 1226120242
Principal investigator 1 GENZYME CORPORATION $8,525.88 01/13/2025 Covered Recipient Teaching Hospital
Methodist Hospitals Inc
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis No dispute reported 06/30/2026 1226120246
Principal investigator 1 Novartis Pharmaceuticals Corporation $12,998.48 01/09/2025 Non-covered Recipient Entity
METHODIST HOSPITALS NEUROSCIENCE INSTITUTE
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190302331